← Leaderboards
John Ross Teijaro
Scripps Research Institute, The
$15,002,692
Attributed
$19,994,768
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,994,768 · 8
By mechanism
R01$15,325,401 · 5
U19$3,657,642 · 1
R21$537,975 · 1
R56$473,750 · 1
Top collaborators
- Peng Wu5 shared
- Donna L Farber4 shared
- Susan M Kaech4 shared
- Vaughn Vasil Smider2 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Mansun Law$19,290,800
- Peng Wu$17,630,509
- Donna L Farber$39,655,805
- Robert F Garry$57,098,933
- Shane P Crotty$52,208,511
Others in their field
Top investigators on “T-Lymphocyte”
- Barton F Haynes · Duke University$296,833,570
- Lawrence Corey · Fred Hutchinson Cancer Center$270,341,865
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,305,894
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$107,651,960
- Alessandro Sette · La Jolla Institute For Immunology$75,756,097
- Rama Rao Amara · Emory University$69,530,112
Research focus
T-LymphocyteVirus DiseasesExhaustionCd8-Positive T-LymphocytesLymphocytic Choriomeningitis VirusAntibodiesSignal TransductionInfectionImmuneVirusCellsViralResponseIn VivoBaseT Cell ResponseImmune ResponseAnimal ModelCell PhysiologyGenerationsCytokineGeneticMouse ModelAntigens
Grant awards (27)
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination$863,551
R01 · FY2025 · AI · contact PI
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.$557,334
R01 · FY2025 · AI · contact PI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination$884,886
R01 · FY2024 · AI · contact PI
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.$548,247
R01 · FY2024 · AI · contact PI
Engineer Immune Cells via Chemoenzymatic Glycan Editing$944,319
R01 · FY2023 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination$878,617
R01 · FY2023 · AI · contact PI
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.$548,247
R01 · FY2023 · AI · contact PI
Animal and Organoid Model Core$3,657,642
U19 · FY2022 · AI · contact PI
Engineer Immune Cells via Chemoenzymatic Glycan Editing$944,319
R01 · FY2022 · AI
The generation and protective function of lung tissue resident memory T cells following SARS-CoV-2 infection or vaccination$916,382
R01 · FY2022 · AI · contact PI
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.$537,646
R01 · FY2022 · AI · contact PI
Engineer Immune Cells via Chemoenzymatic Glycan Editing$944,319
R01 · FY2021 · AI
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.$537,646
R01 · FY2021 · AI · contact PI
Ultralong CDR3 antibodies targeting exhausted T cells$234,525
R21 · FY2021 · AI
Engineer Immune Cells via Chemoenzymatic Glycan Editing$944,319
R01 · FY2020 · AI
IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection$481,250
R01 · FY2020 · AI · contact PI
Ultralong CDR3 antibodies targeting exhausted T cells$303,450
R21 · FY2020 · AI
Engineer Immune Cells via Chemoenzymatic Glycan Editing$944,319
R01 · FY2019 · AI
IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection$481,250
R01 · FY2019 · AI · contact PI
Novel Strategies for Controlling Persistent Viral Infection$481,250
R01 · FY2019 · AI · contact PI
Novel Strategies for Controlling Persistent Viral Infection$481,250
R01 · FY2018 · AI · contact PI
IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection$481,250
R01 · FY2018 · AI · contact PI
Novel Strategies for Controlling Persistent Viral Infection$481,250
R01 · FY2017 · AI · contact PI
IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection$481,250
R01 · FY2017 · AI · contact PI
Novel Strategies for Controlling Persistent Viral Infection$481,250
R01 · FY2016 · AI · contact PI
IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection$481,250
R01 · FY2016 · AI · contact PI
The Role of IL-27 in Controlling Persistent Viral Infection$473,750
R56 · FY2014 · AI · contact PI